In the absence of effective countermeasures, human convalescent plasma has been widely
used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel …

Objectives The current COVID-19 pandemic needs unconventional therapies to tackle the
resulted high morbidity and mortality. Convalescent plasma is one of the therapeutic …

Since the end of 2019, a new coronavirus strain has been reported in the Chinese province
of Wuhan, indicated as 2019-nCoV or SARS-CoV-2. In February 2020, the first case of …

The pathogenesis and immunopathological damage of severe forms of COVID-19 resemble
acute autoimmune disease sparked by SARS-CoV-2, including an early systemic …

Convalescent plasma therapy has been described as an attractive approach to treat critically
ill patients with COVID-19 (Coronavirus disease 2019). The selection of convalescent …

Background Because treatment options for coronavirus disease 2019 (COVID-19) are very
limited, the use of convalescent plasma has bee explored. Case presentation and treatment …

INTRODUCTION. High mortality during the pandemic of COVID-19 conducted the research
for all available treatments. Convalescent plasma (CP) has become valuable empirical …

Abstract Introduction South America is one of the regions most affected by the COVID‐19
pandemic. Specific and affordable treatments are needed to treat SARS‐CoV‐2 infection …

The principle of plasma therapy can be used for prophylaxis and treatment purpose. In view
of non-availability of suitable vaccine for prevention or no established definitive therapy for …

Use of convalescent plasma transfusions could be of great value in the current pandemic of
coronavirus disease (COVID-19), given the lack of specific preventative and therapeutic …